US BUYS THREE MONTHS WORTH OF REMDESIVIR, THE ANTI-VIRAL DRUG FOR COVID19 TREATMENT

Highlights: 

• Remdesivir is an anti-viral drug 
• It is solely produced by Gilead Sciences Inc.
• Was developed for Ebola treatment 

Gilead Science’s remdesivir, initially developed for treating Ebola, has shown immense potential to treat covid19 in its clinical trials. The US has reported in May 2020 that its stock of Remdesivir might not be enough to last the month. Gi....